Stericycle, Inc. Logo

Stericycle, Inc.

SRCL

(0.8)
Stock Price

61,98 USD

1.73% ROA

0.8% ROE

156.71x PER

Market Cap.

5.650.029.390,00 USD

60.06% DER

0% Yield

0.77% NPM

Stericycle, Inc. Stock Analysis

Stericycle, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Stericycle, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (1.68x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

2 DER

The stock maintains a fair debt to equity ratio (72%), indicating a reasonable balance between the money it owes and the ownership it possesses.

3 Buffet Intrinsic Value

The company's stock seems undervalued (8.948) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

4 ROE

The stock's ROE indicates a negative return (-0.18%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-0.25%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Stericycle, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Stericycle, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Stericycle, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Stericycle, Inc. Revenue
Year Revenue Growth
1995 21.300.000
1996 24.500.000 13.06%
1997 46.200.000 46.97%
1998 66.700.000 30.73%
1999 132.800.000 49.77%
2000 323.722.000 58.98%
2001 359.024.000 9.83%
2002 401.519.000 10.58%
2003 453.225.000 11.41%
2004 516.228.000 12.2%
2005 609.457.000 15.3%
2006 789.637.000 22.82%
2007 932.767.000 15.34%
2008 1.083.679.000 13.93%
2009 1.177.736.000 7.99%
2010 1.439.388.000 18.18%
2011 1.676.048.000 14.12%
2012 1.913.149.000 12.39%
2013 2.142.807.000 10.72%
2014 2.555.601.000 16.15%
2015 2.985.908.000 14.41%
2016 3.562.342.000 16.18%
2017 3.580.700.000 0.51%
2018 3.485.900.000 -2.72%
2019 3.308.900.000 -5.35%
2020 2.675.500.000 -23.67%
2021 2.646.900.000 -1.08%
2022 2.704.700.000 2.14%
2023 2.614.000.000 -3.47%
2023 2.659.300.000 1.7%
2024 2.646.400.000 -0.49%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Stericycle, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Stericycle, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1995 0
1996 7.600.000 100%
1997 10.700.000 28.97%
1998 14.900.000 28.19%
1999 26.500.000 43.77%
2000 59.457.000 55.43%
2001 66.086.000 10.03%
2002 60.402.000 -9.41%
2003 69.558.000 13.16%
2004 80.623.000 13.72%
2005 98.032.000 17.76%
2006 144.366.000 32.09%
2007 176.737.000 18.32%
2008 208.805.000 15.36%
2009 227.873.000 8.37%
2010 262.357.000 13.14%
2011 311.522.000 15.78%
2012 356.817.000 12.69%
2013 390.610.000 8.65%
2014 489.937.000 20.27%
2015 712.803.000 31.27%
2016 904.179.000 21.17%
2017 1.470.100.000 38.5%
2018 1.178.400.000 -24.75%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Stericycle, Inc. EBITDA
Year EBITDA Growth
1995 -2.400.000
1996 -800.000 -200%
1997 3.900.000 120.51%
1998 9.900.000 60.61%
1999 37.500.000 73.6%
2000 96.266.000 61.05%
2001 100.379.000 4.1%
2002 120.684.000 16.82%
2003 150.362.000 19.74%
2004 176.622.000 14.87%
2005 235.564.000 25.02%
2006 238.103.000 1.07%
2007 274.555.000 13.28%
2008 308.845.000 11.1%
2009 364.826.000 15.34%
2010 446.213.000 18.24%
2011 510.901.000 12.66%
2012 574.840.000 11.12%
2013 639.622.000 10.13%
2014 714.278.000 10.45%
2015 728.801.000 1.99%
2016 684.075.000 -6.54%
2017 235.300.000 -190.72%
2018 445.200.000 47.15%
2019 382.700.000 -16.33%
2020 383.000.000 0.08%
2021 294.800.000 -29.92%
2022 371.300.000 20.6%
2023 330.000.000 -12.52%
2023 417.800.000 21.01%
2024 395.600.000 -5.61%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Stericycle, Inc. Gross Profit
Year Gross Profit Growth
1995 5.700.000
1996 7.200.000 20.83%
1997 15.200.000 52.63%
1998 25.500.000 40.39%
1999 56.600.000 54.95%
2000 150.846.000 62.48%
2001 143.065.000 -5.44%
2002 164.509.000 13.04%
2003 196.625.000 16.33%
2004 228.206.000 13.84%
2005 268.037.000 14.86%
2006 349.867.000 23.39%
2007 417.921.000 16.28%
2008 485.029.000 13.84%
2009 552.396.000 12.2%
2010 667.427.000 17.23%
2011 760.744.000 12.27%
2012 857.305.000 11.26%
2013 964.634.000 11.13%
2014 1.094.411.000 11.86%
2015 1.206.534.000 9.29%
2016 1.503.212.000 19.74%
2017 1.462.500.000 -2.78%
2018 1.376.000.000 -6.29%
2019 1.174.500.000 -17.16%
2020 1.053.100.000 -11.53%
2021 1.017.200.000 -3.53%
2022 1.025.600.000 0.82%
2023 982.800.000 -4.35%
2023 908.400.000 -8.19%
2024 921.200.000 1.39%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Stericycle, Inc. Net Profit
Year Net Profit Growth
1995 -4.500.000
1996 -2.400.000 -87.5%
1997 1.400.000 271.43%
1998 5.700.000 75.44%
1999 14.000.000 59.29%
2000 14.511.000 3.52%
2001 14.710.000 1.35%
2002 45.724.000 67.83%
2003 65.781.000 30.49%
2004 78.178.000 15.86%
2005 67.154.000 -16.42%
2006 105.270.000 36.21%
2007 118.378.000 11.07%
2008 148.708.000 20.4%
2009 175.691.000 15.36%
2010 207.879.000 15.48%
2011 234.751.000 11.45%
2012 267.996.000 12.41%
2013 311.372.000 13.93%
2014 326.456.000 4.62%
2015 267.078.000 -22.23%
2016 205.969.000 -29.67%
2017 42.400.000 -385.78%
2018 -244.700.000 117.33%
2019 -346.000.000 29.28%
2020 -55.900.000 -518.96%
2021 -26.800.000 -108.58%
2022 56.000.000 147.86%
2023 8.000.000 -600%
2023 -21.400.000 137.38%
2024 24.000.000 189.17%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Stericycle, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 1 0%
2003 1 0%
2004 1 0%
2005 1 0%
2006 1 100%
2007 1 0%
2008 2 0%
2009 2 50%
2010 2 0%
2011 3 0%
2012 3 33.33%
2013 4 0%
2014 4 0%
2015 3 0%
2016 2 -50%
2017 0 0%
2018 -3 100%
2019 -4 33.33%
2020 -1 0%
2021 0 0%
2022 1 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Stericycle, Inc. Free Cashflow
Year Free Cashflow Growth
1995 -1.600.000
1996 -900.000 -77.78%
1997 -1.300.000 30.77%
1998 -19.200.000 93.23%
1999 -414.300.000 95.37%
2000 -1.117.000 -36990.42%
2001 49.138.000 102.27%
2002 82.116.000 40.16%
2003 100.131.000 17.99%
2004 81.299.000 -23.16%
2005 68.013.000 -19.53%
2006 123.748.000 45.04%
2007 125.645.000 1.51%
2008 163.035.000 22.93%
2009 237.336.000 31.31%
2010 277.350.000 14.43%
2011 252.803.000 -9.71%
2012 322.212.000 21.54%
2013 330.358.000 2.47%
2014 362.004.000 8.74%
2015 275.589.000 -31.36%
2016 411.221.000 32.98%
2017 365.600.000 -12.48%
2018 34.900.000 -947.56%
2019 53.800.000 35.13%
2020 410.700.000 86.9%
2021 186.200.000 -120.57%
2022 68.000.000 -173.82%
2023 112.000.000 39.29%
2023 -100.000 112100%
2024 7.700.000 101.3%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Stericycle, Inc. Operating Cashflow
Year Operating Cashflow Growth
1995 -900.000
1996 100.000 1000%
1997 -100.000 200%
1998 4.900.000 102.04%
1999 11.800.000 58.47%
2000 10.469.000 -12.71%
2001 64.550.000 83.78%
2002 96.947.000 33.42%
2003 121.103.000 19.95%
2004 114.611.000 -5.66%
2005 94.327.000 -21.5%
2006 160.162.000 41.11%
2007 174.042.000 7.98%
2008 210.555.000 17.34%
2009 277.246.000 24.05%
2010 325.670.000 14.87%
2011 306.104.000 -6.39%
2012 387.448.000 20.99%
2013 403.467.000 3.97%
2014 448.500.000 10.04%
2015 390.350.000 -14.9%
2016 547.381.000 28.69%
2017 508.600.000 -7.63%
2018 165.700.000 -206.94%
2019 248.000.000 33.19%
2020 530.200.000 53.23%
2021 303.100.000 -74.93%
2022 200.200.000 -51.4%
2023 243.300.000 17.71%
2023 38.400.000 -533.59%
2024 44.000.000 12.73%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Stericycle, Inc. Capital Expenditure
Year Capital Expenditure Growth
1995 700.000
1996 1.000.000 30%
1997 1.200.000 16.67%
1998 24.100.000 95.02%
1999 426.100.000 94.34%
2000 11.586.000 -3577.71%
2001 15.412.000 24.82%
2002 14.831.000 -3.92%
2003 20.972.000 29.28%
2004 33.312.000 37.04%
2005 26.314.000 -26.59%
2006 36.414.000 27.74%
2007 48.397.000 24.76%
2008 47.520.000 -1.85%
2009 39.910.000 -19.07%
2010 48.320.000 17.4%
2011 53.301.000 9.35%
2012 65.236.000 18.3%
2013 73.109.000 10.77%
2014 86.496.000 15.48%
2015 114.761.000 24.63%
2016 136.160.000 15.72%
2017 143.000.000 4.78%
2018 130.800.000 -9.33%
2019 194.200.000 32.65%
2020 119.500.000 -62.51%
2021 116.900.000 -2.22%
2022 132.200.000 11.57%
2023 131.300.000 -0.69%
2023 38.500.000 -241.04%
2024 36.300.000 -6.06%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Stericycle, Inc. Equity
Year Equity Growth
1995 12.600.000
1996 40.000.000 68.5%
1997 45.000.000 11.11%
1998 53.700.000 16.2%
1999 187.300.000 71.33%
2000 206.137.000 9.14%
2001 277.382.000 25.68%
2002 326.729.000 15.1%
2003 407.820.000 19.88%
2004 495.372.000 17.67%
2005 521.634.000 5.03%
2006 625.081.000 16.55%
2007 714.075.000 12.46%
2008 670.480.000 -6.5%
2009 857.173.000 21.78%
2010 1.083.091.000 20.86%
2011 1.227.251.000 11.75%
2012 1.557.323.000 21.19%
2013 1.767.538.000 11.89%
2014 1.917.185.000 7.81%
2015 2.746.185.000 30.19%
2016 2.815.856.000 2.47%
2017 2.908.600.000 3.19%
2018 2.597.100.000 -11.99%
2019 2.334.700.000 -11.24%
2020 2.434.400.000 4.1%
2021 2.402.800.000 -1.32%
2022 2.424.500.000 0.9%
2023 2.522.900.000 3.9%
2023 2.476.300.000 -1.88%
2024 2.532.500.000 2.22%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Stericycle, Inc. Assets
Year Assets Growth
1995 23.500.000
1996 55.200.000 57.43%
1997 61.200.000 9.8%
1998 97.800.000 37.42%
1999 595.800.000 83.59%
2000 597.982.000 0.36%
2001 614.530.000 2.69%
2002 667.095.000 7.88%
2003 707.462.000 5.71%
2004 834.141.000 15.19%
2005 1.047.660.000 20.38%
2006 1.327.906.000 21.1%
2007 1.608.159.000 17.43%
2008 1.758.588.000 8.55%
2009 2.182.803.000 19.43%
2010 2.642.513.000 17.4%
2011 3.177.090.000 16.83%
2012 3.546.738.000 10.42%
2013 3.882.797.000 8.66%
2014 4.401.206.000 11.78%
2015 6.980.870.000 36.95%
2016 6.984.615.000 0.05%
2017 6.988.300.000 0.05%
2018 6.455.500.000 -8.25%
2019 6.437.000.000 -0.29%
2020 5.581.900.000 -15.32%
2021 5.473.100.000 -1.99%
2022 5.334.100.000 -2.61%
2023 5.352.600.000 0.35%
2023 5.246.100.000 -2.03%
2024 5.476.800.000 4.21%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Stericycle, Inc. Liabilities
Year Liabilities Growth
1995 10.900.000
1996 15.200.000 28.29%
1997 16.200.000 6.17%
1998 44.100.000 63.27%
1999 408.500.000 89.2%
2000 391.845.000 -4.25%
2001 337.148.000 -16.22%
2002 340.366.000 0.95%
2003 299.642.000 -13.59%
2004 338.769.000 11.55%
2005 526.026.000 35.6%
2006 702.825.000 25.16%
2007 894.084.000 21.39%
2008 1.088.108.000 17.83%
2009 1.325.630.000 17.92%
2010 1.559.422.000 14.99%
2011 1.949.839.000 20.02%
2012 1.989.415.000 1.99%
2013 2.115.259.000 5.95%
2014 2.484.021.000 14.85%
2015 4.234.685.000 41.34%
2016 4.168.759.000 -1.58%
2017 4.079.700.000 -2.18%
2018 3.858.400.000 -5.74%
2019 4.102.300.000 5.95%
2020 3.147.500.000 -30.34%
2021 3.070.300.000 -2.51%
2022 2.909.600.000 -5.52%
2023 2.829.700.000 -2.82%
2023 2.769.800.000 -2.16%
2024 2.944.300.000 5.93%

Stericycle, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
28.39
Net Income per Share
0.39
Price to Earning Ratio
156.71x
Price To Sales Ratio
2.15x
POCF Ratio
72.42
PFCF Ratio
-81.77
Price to Book Ratio
2.23
EV to Sales
2.87
EV Over EBITDA
19.01
EV to Operating CashFlow
97.06
EV to FreeCashFlow
-109.42
Earnings Yield
0.01
FreeCashFlow Yield
-0.01
Market Cap
5,65 Bil.
Enterprise Value
7,56 Bil.
Graham Number
15.45
Graham NetNet
-26.07

Income Statement Metrics

Net Income per Share
0.39
Income Quality
2.16
ROE
0.01
Return On Assets
0
Return On Capital Employed
0.03
Net Income per EBT
0.51
EBT Per Ebit
0.24
Ebit per Revenue
0.06
Effective Tax Rate
0.49

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.35
Operating Profit Margin
0.06
Pretax Profit Margin
0.01
Net Profit Margin
0.01

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.84
Free CashFlow per Share
-0.75
Capex to Operating CashFlow
1.89
Capex to Revenue
0.06
Capex to Depreciation
0.69
Return on Invested Capital
0.03
Return on Tangible Assets
0.02
Days Sales Outstanding
91.13
Days Payables Outstanding
42.99
Days of Inventory on Hand
0
Receivables Turnover
4.01
Payables Turnover
8.49
Inventory Turnover
0
Capex per Share
1.59

Balance Sheet

Cash per Share
0,38
Book Value per Share
27,32
Tangible Book Value per Share
-9.25
Shareholders Equity per Share
27.31
Interest Debt per Share
17.2
Debt to Equity
0.6
Debt to Assets
0.28
Net Debt to EBITDA
4.8
Current Ratio
1.11
Tangible Asset Value
-0,86 Bil.
Net Current Asset Value
-2,19 Bil.
Invested Capital
4711400000
Working Capital
0,07 Bil.
Intangibles to Total Assets
0.62
Average Receivables
0,64 Bil.
Average Payables
0,20 Bil.
Average Inventory
0.5
Debt to Market Cap
0.27

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Stericycle, Inc. Dividends
Year Dividends Growth

Stericycle, Inc. Profile

About Stericycle, Inc.

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. It also provides secure information destruction services, including document and hard drive destruction services under the Shred-it brand; and communication solutions, such as appointment reminders, secure messaging, event registration, and other communications specifically for hospitals and integrated delivery networks. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.

CEO
Ms. Cindy J. Miller
Employee
13.095
Address
2355 Waukegan Road
Bannockburn, 60015

Stericycle, Inc. Executives & BODs

Stericycle, Inc. Executives & BODs
# Name Age
1 Mr. Joseph Anthony Reuter
Executive Vice President & Chief People Officer
70
2 Andrew Ellis
Vice President of Investor Relations
70
3 Mr. Stephen Cory White
Executive Vice President & Chief Commercial Officer
70
4 Ms. Cindy J. Miller
President, Chief Executive Officer & Director
70
5 Ms. Janet H. Zelenka
Executive Vice President, Chief Financial Officer & Chief Information Officer
70
6 Mr. Kurt M. Rogers
Executive Vice President, General Counsel & Corporate Secretary
70
7 Mr. Daniel V. Ginnetti
Executive Vice President of International
70
8 Mr. Richard Joseph Hoffman
Senior Vice President & Chief Accounting Officer
70
9 Mr. Michael S. Weisman
Executive Vice President and Chief Ethics & Compliance Officer
70
10 Mr. Richard Michael Moore
Executive Vice President of North American Operations
70

Stericycle, Inc. Competitors